How does sharewise work?
Discuss
Discuss and share predictions for your favorite stocks in the forum. Let your opinion be heard
Show moreTop Buy/Sell (This Month)
| Security | Price | Target price |
|---|---|---|
| Amazon.com Inc. | €227.35 | €253.48 |
| ServiceNow Inc. | €81.82 | €156.69 |
| Alphabet Inc. A | €341.45 | €339.04 |
| Security | Price | Target price |
|---|---|---|
| Prudential Financial | €87.70 | €79.37 |
| Whirlpool Corp. | €34.42 | €80.04 |
| Southern Copper | €152.10 | €129.26 |
New Top predictions since last week
| Prediction | User | Perf. (%) |
|---|---|---|
| S Biosynex | Lokrim | -45.42% |
| S Novacyt S.A. | Vassago1 | -45.00% |
| S Regenxbio Inc | Bankster | -40.05% |
Many tell you which stocks to buy.
We measure how often they are right!
Portfolios of our members
1/2DerAlmanach100000
When it comes to stocks, what is important for you?
Find stocks based on your criteria with our sharewise stock finder. All results are based on thousands of votes by our community
Pros and Cons of these stocks (New Predictions)
Xiaomi Corp.
WKN: A2JNY1 / Name: Xiaomi / Stock / Large Cap /
Pros
Cons
VERBIO Vereinigte BioEnergie AG
WKN: A0JL9W / Name: VERBIO / Stock / Renewable Energy / Small Cap /
Pros
Cons
Try sharewise+ and get hundreds more matching stocks
Sign up for free!Tops & Flops S&P 500
| Security | Price | Change(%) (%) |
|---|---|---|
| FMC Corp. | €12.18 | 5.730% |
| Adobe Inc. | €213.05 | 5.690% |
| ServiceNow Inc. | €81.82 | 5.570% |
| Devon Energy Corp. | €42.58 | 5.250% |
| Occidental Petroleum Corp. | €51.29 | 5.150% |
| Security | Price | Change(%) (%) |
|---|---|---|
| Cabot Oil & Gas Corp | €27.72 | -8.130% |
| Micron Technology Inc. | €623.60 | -8.110% |
| Corning Inc. | €165.14 | -7.740% |
| Borgwarner Inc. | €54.40 | -6.890% |
| Ford Motor Co. | €11.55 | -6.560% |
Courses
sharewise advanced features
Also you get more information about our Pro and Cons feature, where we bring the wisdom of crowds to a new level.
For discussing with your friends and managing your investment clubs we will show you how to create your own stock debates.#
Key figures for stocks
Predictions
Top News
CSX Eyes Higher Margins as Freight Demand Improves, CFO Says at Conference
CSX (NASDAQ:CSX) Executive Vice President and Chief Financial Officer Kevin Boone said the railroad remains focused on improving margins, capturing pricing
BioStem Technologies Q1 Earnings Call Highlights
BioStem Technologies (OTCMKTS:BSEM) said its first quarter of 2026 marked a major shift in its business model following a late-January acquisition that moved the company’s focus from physician
CSX Touts 2026 Rebound at Annual Meeting After Tough Year for Rail Operations
CSX (NASDAQ:CSX) used its 2026 annual meeting of shareholders to highlight early-year operating momentum after what executives described as a difficult
Ascend Wellness Q1 Earnings Call Highlights
Ascend Wellness (OTCMKTS:AAWH) reported first-quarter 2026 results that management said came in ahead of its guidance, as the cannabis operator pointed to improving retail mix, higher vertical
Americas Gold and Silver Q1 Earnings Call Highlights
Americas Gold and Silver (NYSEAMERICAN:USAS) reported what management described as a strong start to 2026, citing record consolidated silver production, sharply higher revenue and progress on
Gossamer Bio (GOSS) Reports Q1 Loss, Tops Revenue Estimates
Gossamer Bio (GOSS) came out with a quarterly loss of $0.2 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to a loss of $0.16 per share a year ago. These figures are
Knightscope, Inc. (KSCP) Reports Q1 Loss, Tops Revenue Estimates
Knightscope, Inc. (KSCP) came out with a quarterly loss of $0.74 per share versus the Zacks Consensus Estimate of a loss of $0.52. This compares to a loss of $1.28 per share a year ago. These
zSpace, Inc (ZSPC) Reports Q1 Loss, Lags Revenue Estimates
zSpace, Inc (ZSPC) came out with a quarterly loss of $2.82 per share versus the Zacks Consensus Estimate of a loss of $1.5. This compares to a loss of $6.5 per share a year ago. These figures are
MongoDB (MDB) Rises As Market Takes a Dip: Key Facts
In the latest close session, MongoDB (MDB) was up +2.99% at $312.16. The stock outperformed the S&P 500, which registered a daily loss of 1.24%. Meanwhile, the Dow experienced a drop of 1.07%, and
Xtant Medical Q1 Earnings Call Highlights
Xtant Medical (NYSEAMERICAN:XTNT) raised its full-year 2026 revenue guidance after announcing a distribution agreement that moves the company into the hemostatic agent market, while first-quarter
News
WidePoint Q1 Earnings Call Highlights
WidePoint (NYSEAMERICAN:WYY) reported higher first-quarter revenue, positive adjusted EBITDA and its first quarterly net income since 2021, while management said the company’s 2026 outlook remains
Unusual Machines Q1 Earnings Call Highlights
Unusual Machines (NYSEAMERICAN:UMAC) reported sharply higher first-quarter 2026 revenue and said it is continuing to expand capacity
Ur Energy Q1 Earnings Call Highlights
Ur Energy (NYSEAMERICAN:URG) said production momentum improved at its Lost Creek uranium operation during the first quarter of 2026 and that its
Stereotaxis Q1 Earnings Call Highlights
Stereotaxis (NYSEAMERICAN:STXS) said its first-quarter results did not yet reflect what management described as a major commercial transition
Titan Mining Q1 Earnings Call Highlights
Titan Mining (NYSEAMERICAN:TII) said its first-quarter results reflected steady zinc operations, early progress in graphite shipments and a new effort to evaluate germanium recovery through a
Standard Lithium Q1 Earnings Call Highlights
Standard Lithium (NYSEAMERICAN:SLI) executives said the company remains on track to reach a final investment decision and begin construction in 2026 at
Radiant Logistics Q3 Earnings Call Highlights
Radiant Logistics (NYSEAMERICAN:RLGT) reported higher net income for its fiscal third quarter ended March 31, 2026, while adjusted earnings measures declined from the prior-year period, as
CRISPR Therapeutics Enters 'Second Phase' as CASGEVY Momentum Builds, Pipeline Data Looms
CRISPR Therapeutics (NASDAQ:CRSP) Chief Executive Officer Sam Kulkarni said the company is entering a “second phase” as it moves beyond the
Pelthos Therapeutics Q1 Earnings Call Highlights
Pelthos Therapeutics (NYSEAMERICAN:PTHS) reported higher first-quarter revenue as prescriptions for its lead product, ZELSUVMI, continued to grow in the treatment’s third full quarter since launch
Contest
Still running
sharewise
Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer
sharewise+-Mitgliedschaft
unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.
Heibel Ticker
sharewise sagt: Stephan Heibel ist ein langähriger Unterstützer und Autor der Wunschanalyse. Er betreibt meiner Meinung nach einen der besten Börsenbriefe. Es gibt eine kostenlose und eine Premium Variante.
Kostenlos ausprobieren
Leeway
Die Analyse-Plattform Leeway untersucht mit KI-unterstützten Algorithmen aussagekräftige Zusammenhänge am Aktienmarkt. Anhand von vielen Millionen Datenpunkten finden die Algorithmen die Kennzahlen und Bewegungen, die nachweisbare Auswirkungen haben und Vorteile schaffen.
Kostenlos ausprobierensharewise
Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer
sharewise+-Mitgliedschaft
unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.